Factors | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Gender | 0.570 (0.458–0.709) | < 0.001 | 0.665 (0.496–0.892) | 0.006 |
Age (year) | 1.018 (1.007–1.029) | 0.002 | 1.012 (1.001–1.023) | 0.039 |
Tumor size (cm) | 1.402 (1.278–1.538) | < 0.001 | 1.232 (1.089–1.394) | 0.001 |
Smoking history | 1.537 (1.258–1.877) | < 0.001 | 1.026 (0.780–1.348) | 0.856 |
8th TNM stage | 1.938 (1.570–2.393) | < 0.001 | 1.386 (0.997–1.928) | 0.052 |
Visceral pleural invasion | 1.333 (1.088–1.631) | 0.005 | 1.053 (0.799–1.373) | 0.709 |
Histology | ||||
Squamous cell carcinoma | Ref | Ref | ||
Adenocarcinoma | 0.782 (0.611–0.999) | 0.049 | 1.222 (0.926–1.614) | 0.157 |
Others | 0.946 (0.666–1.433) | 0.905 | 1.179 (0.789–1.762) | 0.422 |
Differentiation degree | 1.559 (1.323–1.838) | < 0.001 | 1.338 (1.124–1.592) | 0.001 |
Vascular invasion | 1.982 (1.378–2.852) | < 0.001 | 1.474 (1.006–2.160) | 0.047 |
Number of N2 LNs examined | ||||
0–2 | Ref | |||
3–5 | 0.627 (0.391–1.005) | 0.052 | 0.730 (0.451–1.180) | 0.199 |
6–8 | 0.841 (0.545–1.297) | 0.433 | 0.916 (0.590–1.423) | 0.696 |
9–11 | 0.737 (0.470–1.156) | 0.183 | 0.826 (0.522–1.307) | 0.413 |
12–14 | 0.730 (0.463–1.151) | 0.175 | 0.869 (0.545–1.385) | 0.554 |
> 14 | 0.759 (0.505–1.142) | 0.186 | 0.665 (0.555–1.285) | 0.431 |
Adjuvant chemotherapy | 1.127 (0.858–1.481) | 0.500 | ||
Thoracotomy or VATS | 0.933 (0.763–1.141) | 0.304 | ||
Number of N1 stations examined | ||||
0–2 | Ref | Ref | ||
3–5 | 0.654 (0.464–0.922) | 0.015 | 0.640 (0.452–0.906) | 0.012 |
6–8 | 0.680 (0.486–0.949) | 0.024 | 0.658 (0.469–0.924) | 0.016 |
9–11 | 0.595 (0.418–0.847) | 0.004 | 0.585 (0.407–0.839) | 0.004 |
> 11 | 0.627 (0.445–0.884) | 0.008 | 0.557 (0.391–0.793) | 0.001 |